RIVENDELL ARKANSAS — History
CCN 044007 | 3-year financial timeline | COVID resilience: 46/100
🛡️ Public data only — no PHI permitted on this instance.
$20M
Latest Revenue (FY2022)
+0.7%
Revenue CAGR (3yr)
28.5%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $20M | $20M | $20M | +1.1% | +0.7% |
| Operating Expenses | $13M | $14M | $15M | +2.6% | +5.8% |
| Operating Margin | 35.2% | 29.6% | 28.5% | -3.6% | -10.0% |
| Net Income | $7M | $6M | $6M | -2.5% | -9.3% |
| Licensed Beds | 72 | 72 | 79 | +9.7% | +4.7% |
| Total Patient Days | 17,268 | 19,763 | 20,099 | +1.7% | +7.9% |
| Medicare Day % | 10% | 5% | 7% | +41.8% | -16.4% |
| Medicaid Day % | 18% | 19% | 12% | -37.3% | -19.6% |
COVID Impact & Recovery
Resilience Score: 46/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +1.5% ($20M → $20M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▶ Stable
Operating Margin▼ Declining
Beds▲ Growing
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+0.7%
This Hospital
+7.6%
State Avg
Latest Margin
28.5%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $21M | 25.2% |
| FY2024 (proj) | $21M | 21.9% |
| FY2025 (proj) | $21M | 18.5% |